Browse Category

Stock Market News News 12 December 2025

Carvana Stock (CVNA) News Today: S&P 500 Addition, Analyst Forecasts, Valuation Risks, and the 2026 Outlook (Dec. 12, 2025)

Carvana Stock (CVNA) News Today: S&P 500 Addition, Analyst Forecasts, Valuation Risks, and the 2026 Outlook (Dec. 12, 2025)

Carvana Co. (NYSE: CVNA) is ending 2025 in the spotlight again—this time for a very different reason than the “survival” headlines that dominated the company’s story a few years ago. As of Friday, Dec. 12, 2025, Carvana shares were trading
Salesforce (CRM) Stock News Today (Dec. 12, 2025): ValueAct’s $25M Insider Buy, FY2026 Forecast, and Agentforce Pricing Signals

Salesforce (CRM) Stock News Today (Dec. 12, 2025): ValueAct’s $25M Insider Buy, FY2026 Forecast, and Agentforce Pricing Signals

Updated: December 12, 2025 Salesforce, Inc. (NYSE: CRM) is back in the spotlight on December 12, 2025 as investors balance three narratives that often pull software stocks in different directions: (1) a fresh, high-profile insider purchase tied to ValueAct, (2)
Mastercard (MA) Stock News Today: $14B Buyback, Dividend Hike, and Analyst Targets — What Investors Are Watching on Dec. 12, 2025

Mastercard (MA) Stock News Today: $14B Buyback, Dividend Hike, and Analyst Targets — What Investors Are Watching on Dec. 12, 2025

Mastercard stock has been in focus after the company announced a bigger dividend and a new $14 billion share repurchase authorization. Here’s the latest MA stock news, analyst forecasts, and key risks investors are tracking. Mastercard Incorporated (NYSE: MA) is
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

December 12, 2025 — Cronos Group Inc. (NASDAQ: CRON , TSX: CRON ) is back in the spotlight after cannabis stocks jumped broadly into early trading on reports that the Trump administration could pursue a major easing of federal marijuana
UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group Incorporated (NYSE: UNH) stock is back in focus on December 12, 2025, after a strong Thursday rebound put the health-insurance giant near a closely watched technical zone around $340—while investors continue to weigh a busy mix of antitrust
RH Stock News Today (Dec. 12, 2025): Q3 Earnings, 2025 Guidance, Analyst Price-Target Cuts, and What’s Next for RH (NYSE :RH )

RH Stock News Today (Dec. 12, 2025): Q3 Earnings, 2025 Guidance, Analyst Price-Target Cuts, and What’s Next for RH (NYSE :RH )

RH stock (NYSE: RH) is back in the spotlight on Friday, December 12, 2025 , after the luxury home-furnishings retailer released third-quarter fiscal 2025 results late Thursday and investors digested a fresh wave of analyst note updates, price-target cuts, and
Disney Stock (DIS) News, Forecasts and Analysis: OpenAI Sora Deal, Google Copyright Clash, and What’s Next for Shares (Dec. 12, 2025)

Disney Stock (DIS) News, Forecasts and Analysis: OpenAI Sora Deal, Google Copyright Clash, and What’s Next for Shares (Dec. 12, 2025)

Disney stock (NYSE: DIS) is in focus on Dec. 12, 2025 after a $1 billion OpenAI investment and a new copyright fight with Google. Here’s the latest news, analyst forecasts, and key catalysts for 2026. The Walt Disney Company (NYSE:
Katapult Holdings (KPLT) Stock Surges on Aaron’s–CCF All-Stock Deal: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Katapult Holdings (KPLT) Stock Surges on Aaron’s–CCF All-Stock Deal: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Katapult Holdings, Inc. (NASDAQ: KPLT ) is in the spotlight on December 12, 2025 after announcing a transformational, all-stock combination with The Aaron’s Company, Inc. and CCF Holdings LLC —a move management says will create a scaled, omni-channel platform aimed
SNDL Stock Jumps on Marijuana Rescheduling Headlines: Latest News (Dec. 12, 2025), Forecasts, and What Investors Are Watching

SNDL Stock Jumps on Marijuana Rescheduling Headlines: Latest News (Dec. 12, 2025), Forecasts, and What Investors Are Watching

SNDL Inc. (NASDAQ: SNDL) is in focus on Friday, December 12, 2025 , after cannabis stocks broadly moved higher on fresh reporting that the Trump administration could pursue a major shift in US federal marijuana policy—an ongoing catalyst that can
Prudential plc Stock News Today (12 December 2025): PRU Shares Steady as ICICI Prudential AMC IPO Opens, Buyback Continues, Analysts Lift Targets

Prudential plc Stock News Today (12 December 2025): PRU Shares Steady as ICICI Prudential AMC IPO Opens, Buyback Continues, Analysts Lift Targets

Prudential plc (LSE: PRU; HKEX: 2378) finished Friday, 12 December 2025, with its London-listed shares hovering close to recent highs as investors digested a fast-moving mix of catalysts: the opening of the ICICI Prudential Asset Management (IPAMC) IPO in India,
Lululemon CEO Calvin McDonald to Step Down: What It Means for LULU Stock Price, Earnings Outlook, and Wall Street Forecasts (Dec. 12, 2025)

Lululemon CEO Calvin McDonald to Step Down: What It Means for LULU Stock Price, Earnings Outlook, and Wall Street Forecasts (Dec. 12, 2025)

Lululemon Athletica (NASDAQ: LULU) is heading into 2026 with a major leadership transition—and investors are trying to decide whether this is the reset the brand needs, or another sign that its North American growth engine is still sputtering. Late Thursday,
GSK Stock News Today (Dec. 12, 2025): Arexvy EU Expansion, Blujepa FDA Approval, Analyst Forecasts and What’s Next

GSK Stock News Today (Dec. 12, 2025): Arexvy EU Expansion, Blujepa FDA Approval, Analyst Forecasts and What’s Next

Published: 12 December 2025 GSK plc stock is back in focus on Friday as investors digest a fast-moving cluster of regulatory headlines across vaccines, infectious diseases and oncology—alongside ongoing buybacks and fresh consensus forecasts that map out how GSK’s revenue
1 12 13 14 15 16 29
Go toTop